524 related articles for article (PubMed ID: 27496060)
41. Genetic Basis for Variation of Metalloproteinase-Associated Biochemical Activity in Venom of the Mojave Rattlesnake (Crotalus scutulatus scutulatus).
Dagda RK; Gasanov S; De La Oiii Y; Rael ED; Lieb CS
Biochem Res Int; 2013; 2013():251474. PubMed ID: 23984070
[TBL] [Abstract][Full Text] [Related]
42. Isolation and characterization of two disintegrins inhibiting ADP-induced human platelet aggregation from the venom of Crotalus scutulatus scutulatus (Mohave Rattlesnake).
Sánchez EE; Galán JA; Russell WK; Soto JG; Russell DH; Pérez JC
Toxicol Appl Pharmacol; 2006 Apr; 212(1):59-68. PubMed ID: 16084550
[TBL] [Abstract][Full Text] [Related]
43. Biological and Biochemical Characterization of Coronado Island Rattlesnake (
Franco-Servín C; Neri-Castro E; Bénard-Valle M; Alagón A; Rosales-García RA; Guerrero-Alba R; Poblano-Sánchez JE; Silva-Briano M; Guerrero-Barrera AL; Sigala-Rodríguez JJ
Toxins (Basel); 2021 Aug; 13(8):. PubMed ID: 34437453
[TBL] [Abstract][Full Text] [Related]
44. Neutralization of venoms from two Southern Pacific Rattlesnakes (Crotalus helleri) with commercial antivenoms and endothermic animal sera.
Galán JA; Sánchez EE; Rodríguez-Acosta A; Pérez JC
Toxicon; 2004 Jun; 43(7):791-9. PubMed ID: 15284013
[TBL] [Abstract][Full Text] [Related]
45. Isolation of a hemorrhagic toxin from Mojave rattlesnake (Crotalus scutulatus scutulatus) venom.
Martinez M; Rael ED; Maddux NL
Toxicon; 1990; 28(6):685-94. PubMed ID: 2205951
[TBL] [Abstract][Full Text] [Related]
46. Enzyme-linked immunosorbant assay (ELISA) of size-selected crotalid venom antigens by Wyeth's polyvalent antivenom.
Schaeffer RC; Randall H; Resk J; Carlson RW
Toxicon; 1988; 26(1):67-76. PubMed ID: 3347932
[TBL] [Abstract][Full Text] [Related]
47. Crotalidae polyvalent immune Fab (ovine) antivenom is efficacious for envenomations by Southern Pacific rattlesnakes (Crotalus helleri).
Bush SP; Green SM; Moynihan JA; Hayes WK; Cardwell MD
Ann Emerg Med; 2002 Dec; 40(6):619-24. PubMed ID: 12447339
[TBL] [Abstract][Full Text] [Related]
48. Isolation, characterization and crystallization of a phospholipase A2 myotoxin from the venom of the prairie rattlesnake (Crotalus viridis viridis).
Ownby CL; Colberg TR; White SP
Toxicon; 1997 Jan; 35(1):111-24. PubMed ID: 9028014
[TBL] [Abstract][Full Text] [Related]
49. Venom Composition in a Phenotypically Variable Pit Viper ( Trimeresurus insularis) across the Lesser Sunda Archipelago.
Jones BK; Saviola AJ; Reilly SB; Stubbs AL; Arida E; Iskandar DT; McGuire JA; Yates JR; Mackessy SP
J Proteome Res; 2019 May; 18(5):2206-2220. PubMed ID: 30958009
[TBL] [Abstract][Full Text] [Related]
50. Amino acid sequence of the basic subunit of Mojave toxin from the venom of the Mojave rattlesnake (Crotalus s. scutulatus).
Aird SD; Kruggel WG; Kaiser II
Toxicon; 1990; 28(6):669-73. PubMed ID: 2402763
[TBL] [Abstract][Full Text] [Related]
51. Intraspecies differences in hemostatic venom activities of the South American rattlesnakes, Crotalus durissus cumanensis, as revealed by a range of protease inhibitors.
Salazar AM; Aguilar I; Guerrero B; Girón ME; Lucena S; Sánchez EE; Rodríguez-Acosta A
Blood Coagul Fibrinolysis; 2008 Sep; 19(6):525-30. PubMed ID: 18685436
[TBL] [Abstract][Full Text] [Related]
52. A phospholipase A2-like pseudogene retaining the highly conserved introns of Mojave toxin and other snake venom group II PLA2s, but having different exons.
John TR; Smith JJ; Kaiser II
DNA Cell Biol; 1996 Aug; 15(8):661-8. PubMed ID: 8769568
[TBL] [Abstract][Full Text] [Related]
53. General characterization of the venoms from two species of rattlesnakes and an intergrade population (C. lepidus x aquilus) from Aguascalientes and Zacatecas, Mexico.
Rivas E; Neri-Castro E; Bénard-Valle M; Hernánez-Dávila AI; Zamudio F; Alagón A
Toxicon; 2017 Nov; 138():191-195. PubMed ID: 28890171
[TBL] [Abstract][Full Text] [Related]
54. Characterization of two arginine ester hydrolases from Mojave rattlesnake (Crotalus scutulatus scutulatus) venom.
Schwartz MW; Bieber AL
Toxicon; 1985; 23(2):255-69. PubMed ID: 4024135
[TBL] [Abstract][Full Text] [Related]
55. A Review of Rattlesnake Venoms.
Phan P; Deshwal A; McMahon TA; Slikas M; Andrews E; Becker B; Kumar TKS
Toxins (Basel); 2023 Dec; 16(1):. PubMed ID: 38276526
[TBL] [Abstract][Full Text] [Related]
56. Characterization of the major metalloprotease isolated from the venom of the northern pacific rattlesnake, Crotalus viridis oreganus.
Mackessy SP
Toxicon; 1996; 34(11-12):1277-85. PubMed ID: 9027983
[TBL] [Abstract][Full Text] [Related]
57. Functional characterizations of venom phenotypes in the eastern diamondback rattlesnake (Crotalus adamanteus) and evidence for expression-driven divergence in toxic activities among populations.
Margres MJ; Walls R; Suntravat M; Lucena S; Sánchez EE; Rokyta DR
Toxicon; 2016 Sep; 119():28-38. PubMed ID: 27179420
[TBL] [Abstract][Full Text] [Related]
58. The detection of hemorrhagic proteins in snake venoms using monoclonal antibodies against Virginia opossum (Didelphis virginiana) serum.
Sánchez EE; García C; Pérez JC; De La Zerda SJ
Toxicon; 1998 Oct; 36(10):1451-9. PubMed ID: 9723843
[TBL] [Abstract][Full Text] [Related]
59. Venom composition of adult Western Diamondback Rattlesnakes (Crotalus atrox) maintained under controlled diet and environmental conditions shows only minor changes.
Rex CJ; Mackessy SP
Toxicon; 2019 Jun; 164():51-60. PubMed ID: 30954451
[TBL] [Abstract][Full Text] [Related]
60. A Clot Twist: Extreme Variation in Coagulotoxicity Mechanisms in Mexican Neotropical Rattlesnake Venoms.
Seneci L; Zdenek CN; Chowdhury A; Rodrigues CFB; Neri-Castro E; Bénard-Valle M; Alagón A; Fry BG
Front Immunol; 2021; 12():612846. PubMed ID: 33815366
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
